Biotech companies in the United States by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Scholar Rock Holding leads the 20 biotech companies in the United States ranked by short interest, at 19.2%, ahead of Twist Bioscience (14.4%) and Kodiak Sciences (12.4%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
20
First
Scholar Rock Holding19.2%
Median
9.77%
Combined market value
NOK 7.27T
Countries
1

Market values as of .

United States
All sectors
Biotech
NOK
Clear filters
Biotech companies in the United States by short interest
#CompanyShort interest % ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Scholar Rock HoldingSRRK · Health Care19.2%NOK 61.6BNOK 504.63 2.74% up 25% up United States
2Twist BioscienceTWST · Health Care14.4%NOK 69BNOK 1,012.04 7.02% down 291% up United States
3Kodiak SciencesKOD · Health Care12.4%NOK 64BNOK 978.93 2.54% up 371% up United States
4Halozyme TherapeuticsHALO · Health Care12.0%NOK 103.6BNOK 908.58 0.15% up 32% up United States
5ImmunityBioIBRX · Health Care11.9%NOK 65.8BNOK 61.82 3.50% down 216% up United States
6RepligenRGEN · Health Care11.0%NOK 105.4BNOK 1,648.21 0.74% down 5% up United States
7ExelixisEXEL · Health Care10.5%NOK 158.8BNOK 650.61 1.35% up 55% up United States
8CG OncologyCGON · Health Care10.3%NOK 71.9BNOK 804.53 0.74% up 93% up United States
9Krystal BiotechKRYS · Health Care10.3%NOK 92.6BNOK 3,125.04 1.47% up 49% up United States
10Kymera TherapeuticsKYMR · Health Care9.84%NOK 97.5BNOK 1,142.07 1.90% down 81% up United States
11VaxcytePCVX · Health Care9.70%NOK 89.6BNOK 566.16 0.51% down 22% up United States
12ImmunovantIMVT · Health Care8.96%NOK 65.7BNOK 317.60 0.15% up 44% up United States
13ModernaMRNA · Health Care8.20%NOK 814.8BNOK 2,013.64 3.60% up 740% up United States
14Adaptive BiotechnologiesADPT · Health Care7.09%NOK 44.2BNOK 272.74 0.29% down 51% up United States
15Revolution MedicinesRVMD · Health Care6.05%NOK 350.8BNOK 1,621.93 4.33% up 125% up United States
16Neurocrine BiosciencesNBIX · Health Care5.83%NOK 152.9BNOK 1,510.96 1.05% down 10% up United States
17Bio-TechneTECH · Health Care4.90%NOK 111.4BNOK 709.31 0.06% up 18% up United States
18BiogenBIIB · Health Care3.69%NOK 364.2BNOK 2,463.47 2.23% up 41% up United States
19AmgenAMGN · Health Care2.33%NOK 2.34TNOK 4,320.26 1.55% up 30% up United States
20Gilead SciencesGILD · Health Care1.72%NOK 2.05TNOK 1,656.35 2.00% up 31% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7513 NOK).

Questions and answers

Which biotech companies in the United States rank first by short interest?

Scholar Rock Holding (19.2%), Twist Bioscience (14.4%) and Kodiak Sciences (12.4%) are the top three of the 20 biotech companies in the United States ranked by short interest as of the 30 Oct 2026 settlement date.

How many biotech companies in the United States are in this ranking?

20 are ranked by short interest.

What are these biotech companies in the United States worth together?

The 20 biotech companies in the United States ranked by short interest have a combined market value of NOK 7.27T as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Biotech companies in the United States by short interest”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.